by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana, Chronic Pain, Cluster Headaches, Microdosing
New research published in the European Journal of Pain is offering some of the first clinical trial insights into the efficacy of microdosing THC to treat chronic pain. The results of the small trial suggest minute doses of THC may confer clinically apparent...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana, CBC, Psilocybin Magic Mushroom
The state of Oregon will officially vote on legalizing psilocybin psychotherapy in the upcoming November election, after well over 150,000 signatures were collected to secure the landmark ballot measure. The initiative focuses on licensed and regulated...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana, CBC, Psilocybin Magic Mushroom
A new review from neuroethicist Eddie Jacobs, and published in the Journal of Psychedelic Studies, is suggesting psilocybin may have great potential as a treatment for obsessive-compulsive disorder (OCD). Jacobs, from King’s College London and the University of...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana, CBC
Positive results from the world’s first clinical trial testing the potential for cannabidiol (CBD) to treat cannabis addiction suggest daily use of medical-grade CBD is both safe and effective at reducing problematic cannabis consumption. The researchers quickly...
by EmpathiCSubstanceS | Apr 25, 2021 | Psilocybin Magic Mushroom
After waiting more than 100 days for a response, four terminally ill cancer patients have now been approved to use psilocybin to treat end-of-life distress. These patients will be the first to legally use the psychedelic in Canada for almost half a century following...
